Dechra revenue rises 19 pct; sells services business
July 10 (Reuters) - Animal health company Dechra Pharmaceuticals Plc reported a 19 percent increase in full-year revenue but said it expects the current financial year to remain challenging.
"Although trading in Q4 was good, it did not offset U.S. supply issues and the effect of poor weather experienced in Q3," Chief Executive Ian Page said in a statement.
The company also said it would sell its services business, including National Veterinary Services, Dechra Laboratory Services and Dechra Specialist Laboratories, to Patterson Companies Inc for 87.5 million pounds ($129.77 million) in cash.
- U.S. Mega Millions lottery up to $400 million, 2nd-biggest ever
- Pope Francis named Time's Person of the Year |
- Uruguay becomes first country to legalize marijuana trade
- Thousands of South Africans line up to see Mandela lie in state |
- China bitcoin arbitrage ends as traders work around capital controls